These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6991793)

  • 41. Proteolytic capacity in human plasma. I. Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations.
    Jacobsen CD
    Scand J Clin Lab Invest; 1968; 21(3):216-26. PubMed ID: 4236912
    [No Abstract]   [Full Text] [Related]  

  • 42. [Physiopathology and clinical picture of hereditary antiproteinase deficiency syndromes].
    Duck HJ
    Z Gesamte Inn Med; 1971 Jul; 26(14):445-51. PubMed ID: 4939580
    [No Abstract]   [Full Text] [Related]  

  • 43. [Blood proteolytic activity in patients with viral hepatitis].
    Kajzer J
    Pol Tyg Lek; 1968 May; 23(20):736-9. PubMed ID: 5654447
    [No Abstract]   [Full Text] [Related]  

  • 44. [Demonstration and quantitative determination of complexes between leukocyte protease and 1 -antitrypsin in body secretions and body fluids].
    Hochstrasser K; Schuster R; Reichert R; Heimburger N
    Hoppe Seylers Z Physiol Chem; 1972 Jul; 353(7):1120-4. PubMed ID: 4672514
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the antiproteolytic serum capacity in urticaria pigmentosa].
    Buchholz W; Duck HJ; Barth J
    Dermatol Monatsschr; 1972 Feb; 158(2):116-21. PubMed ID: 4260840
    [No Abstract]   [Full Text] [Related]  

  • 46. [Some data on the dynamics of proteolytic and trypsin-inhibiting activity of blood serum from patients with schizophrenia].
    OLEINIK AV
    Fiziol Zh; 1962; 8():405-9. PubMed ID: 14481723
    [No Abstract]   [Full Text] [Related]  

  • 47. [Inhibition capacity of serum for proteolytic enzymes during massive hemorrhages and in the pathogenesis of shock].
    Duck HJ; Ebeling K; Wagner J
    Z Gesamte Inn Med; 1971 Jun; 26(12):Suppl:147-51. PubMed ID: 5122593
    [No Abstract]   [Full Text] [Related]  

  • 48. Screening for cystic fibrosis.
    Phillips B; Davis JA; Goode M
    Lancet; 1979 Jun; 1(8128):1238-9. PubMed ID: 87697
    [No Abstract]   [Full Text] [Related]  

  • 49. On the origin of urinary trypsin inhibitor.
    Aroor AR; Pattabiraman TN
    Indian J Exp Biol; 1979 May; 17(5):532-3. PubMed ID: 521072
    [No Abstract]   [Full Text] [Related]  

  • 50. [Proteolytic enzyme inhibition and enzyme therapy in chronic nonspecific lung diseases].
    Protsenko VA; Veselov VF; Kanchik IU; Protsenko AV
    Sov Med; 1983; (3):7-11. PubMed ID: 6190232
    [No Abstract]   [Full Text] [Related]  

  • 51. Lipoproteins in infectious and serum hepatitis.
    PIERCE FT; KIMMEL JR; BURNS TW
    Metabolism; 1954 May; 3(3):228-39. PubMed ID: 13165046
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fractionation of the beta-lipoproteins of the blood of subjects with hepatocellular jaundice and obstructive jaundice, using gel filtration on an agarose column].
    Padolecchia N; Maggi S; Fasano V; Trotta M; De Ceglie N; Rotunno F
    Boll Soc Ital Biol Sper; 1968 Sep; 44(18):1533-5. PubMed ID: 5732926
    [No Abstract]   [Full Text] [Related]  

  • 53. [Activity of proteolytic enzymes and their inhibitors in the granulocytes of infants with acute pneumonia].
    Mazurek A; Pajdak E; Pajdak W
    Folia Med Cracov; 1986; 27(1-2):53-63. PubMed ID: 3525354
    [No Abstract]   [Full Text] [Related]  

  • 54. [Serum antitrypsin activity].
    Grigorian VG; Kiroshka VS; Kiriiak LN; Moskovchuk AF; Korkus EN
    Ter Arkh; 1982; 54(4):30-3. PubMed ID: 7101152
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of prophenoloxidase-activating enzyme from Bombyx mori by endogenous chymotrypsin inhibitors.
    Aso Y; Yamashita T; Meno K; Murakami M
    Biochem Mol Biol Int; 1994 Jul; 33(4):751-8. PubMed ID: 7981662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteolytic activity of human blood leukocytes toward synthetic trypsin substrate. I. Method.
    Szczeklik A; Teresiak T
    Acta Med Pol; 1969; 10(4):383-7. PubMed ID: 5366841
    [No Abstract]   [Full Text] [Related]  

  • 57. [Plasma middle mass molecules in viral hepatitis].
    Nagoev BS; Gabrilovich MI; Kimova IA
    Ter Arkh; 1998; 70(11):26-7. PubMed ID: 9949452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
    Yamazaki K; Suzuki K; Nakamura A; Sato S; Lindor KD; Batts KP; Tarara JE; Kephart GM; Kita H; Gleich GJ
    Hepatology; 1999 Jul; 30(1):71-8. PubMed ID: 10385641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Activity of enzymatic systems of serum following single injection of immune complexe to rabbits (author's transl)].
    Stefanovic J; Obsitníková A; Murgasová I
    Bratisl Lek Listy; 1976 Jan; 65(1):15-22. PubMed ID: 1247913
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparative studies of proteolytic and transaminase activity of serum].
    JANOUSEK S
    Cas Lek Cesk; 1959 Feb; 98(7):206-9. PubMed ID: 13639005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.